<DOC>
	<DOC>NCT00925106</DOC>
	<brief_summary>The pharmacokinetics of new formulations of celecoxib are being evaluated. They are expected to provide more favorable bioavailability characteristics than the present commercial formulation.</brief_summary>
	<brief_title>Pharmacokinetics Of Celecoxib Test Formulations</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Healthy male or female volunteers Body weight BMI 17.530.5 Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurological, or allergic disease Positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Bioavailability, pharmacokinetics, celecoxib</keyword>
</DOC>